Genetic studies in neural tube defects

Pediatric Neurosurgery

Volumn 32, Issue 1, 2000, Pages 1-9

  Melvin, Elizabeth C ^a   George, Timothy M ^a   Worley, Gordon ^a   Franklin, Amy ^a   Mackey, Joanne ^a   Viles, Kristi ^a   Shah, Nishu ^a   Drake, Courtney R ^a   Enterline, David S ^a   McLone, David ^b   Nye, Jeffrey ^c   Oakes, W Jerry ^d   McLaughlin, Colleen ^d   Walker, Marion L ^f   Peterson, Paula ^f   Brei, Timothy ^g   Buran, Connie ^g   Aben, Joanna ^e   Ohm, Bonnie ^h   Bermans, Iskandar ^h   Qumsiyeh, Mazin ^a   Vance, Jeffrey ^a   Pericak Vance, Margaret A ^a   Speer, Marcy C ^a   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Children's Rehabilitation Service   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Genetic studies; Spina bifida

Indexed keywords

FOLIC ACID; METHYLENETETRAHYDROFOLATE DEHYDROGENASE;

ANTICONVULSANT THERAPY; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME REARRANGEMENT; ENVIRONMENTAL FACTOR; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENE MUTATION; GENETIC ANALYSIS; HEREDITY; MATERNAL DIABETES MELLITUS; MECKEL SYNDROME; NEURAL TUBE DEFECT; OBESITY; PENETRANCE; PRIORITY JOURNAL; RECURRENCE RISK; SEGREGATION ANALYSIS; SPINA BIFIDA; TRISOMY 13; TRISOMY 18; WAARDENBURG SYNDROME;

EID: 0034075326     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028889     Document Type: Article

References (98)

1. Centers for Disease Control and Prevention: Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morbidity Mortality Weekly 1992;41:1-7.
2. Copp AJ, Brook FA, Estibeiro JP, Shum ASW, Cockcroft DL: The embryonic development of mammalian neural tube defects. Prog Neurobiol 1990;35:363-403.
3. George TM, Wolpert CM, Worley G, Mackey JF, Fuchs HE, Speer MC: Variable presentation of neural tube defects in three families. Am J Hum Genet 1996;59:A93.
4. Schoenwolf GC, Smith GL: Mechanisms of neurulation: Traditional viewpoint and recent advances. Development 1990;109:243-270.
5. Schoenwolf GC: Histological and ultrastructural studies of secondary neurulation in mouse embryos. Am J Anat 1984;169:361-376.
6. Hibbard BM: The role of folic acid in pregnancy with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonwealth 1964;71:529-542.
7. Milunsky A, Jick H, Jick SS, et al: Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1991;262:2847-2852.
8. Medical Research Council Vitamin Study Research Group: Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-137.
9. Seller MJ: Risks in spina bifida. Dev Med Child Neurol 1994;36:1021-1025.
10. Main DM, Mennuti MT: Neural tube defects: Issues in prenatal diagnosis and counselling. Obstet Gynecol 1986;67:1-16.
11. Robert E, Guibaud P: Maternal valproic acid and congenital neural tube defects. Lancet 1982;ii:937.
12. Lammer EJ, Sever LE, Oakley GP: Teratogen update: Valproic acid. Teratology 1987;35:465-473.
13. Rosa FW: Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991;324:674-677.
14. Werler MM, Louik C, Shapiro S, Mitchell AA: Prepregnant weight in relation to risk of neural tube defects. JAMA 1996;275:1089-1092.
15. Shaw GM, Velie EM, Schaffer D: Risk of neural tube defect - Affected pregnancies among obese women. JAMA 1996;275:1093-1096.
16. Watkins ML, Scanlon KS, Mulinare J, Muin JK: Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology 1996;7:507-512.
17. Elwood JM, Little J, Elwood JH: Epidemiology and Control of Neural Tube Defects. Oxford, Oxford University Press, 1992.
18. Demenais F, Le Merrer M, Briard ML, Elston RC: Neural tube defects in France: Segregation analysis. Am J Med Genet 1982;11:287-298.
19. Fineman RM, Jorde LB, Martin RA, Hasstedt SJ, Wing SD, Walker ML: Spinal dysraphia as an autosomal dominant defect in four families. Am J Med Genet 1982;12:457-464.
20. Shaffer LG, Marazita ML, Bodurtha J, Newlin A, Nance WE: Evidence for a major gene in familial anencephaly. Am J Med Genet 1990;36:97-101.
21. Newton R, Stanier P, Loughna S, et al: Linkage analysis of 62 X-chromosomal loci excludes the X chromosome in an Icelandic family showing apparent X-linked recessive inheritance of neural tube defects. Clin Genet 1994;45:241-249.
22. Chatkupt S, Speer MC, Ding Y, et al: Linkage analysis of a candidate locus (HLA) in autosomal dominant sacral defect with anterior meningocele. Am J Med Genet 1994;52:1-4.
23. Fellous M, Boue J, Malbrunot C, et al: A five-generation family with sacral agenesis and spina bifida: Possible similarities with the mouse T-locus. Am J Med Genet 1982;12:465-487.
24. Byrne J, Warburton D: Neural tube defects in spontaneous abortions. Am J Med Genet 1986;25:327-333.
25. Haupt R, Bryne J, Defferrari R, et al: Cytogenetics of the tissue involved in neural tube defects. Genet Couns 1995;6:49-53.
26. Hume RF, Drugan A, Reichler A, et al: Aneuploidy among prenatally detected neural tube defects. Am J Med Genet 1996;61:171-173.
27. Babcook CJ, Goldstein RB: Prenatally detected fetal myelomeningocele: Is Karyotype analysis warranted? Radiology 1995;194:491-494.
28. Kennedy D, Chitayat D, Winsor EJT, Silver M, Toi A: Prenatally diagnosed neural tube defects: Ultrasound, chromosome, and autopsy or postnatal findings in 212 cases. Am J Med Genet 1998;77:317-321.
29. Munke M: Clinical, cytogenetic, and molecular approaches to the genetic heterogeneity of holoprosencephaly. Am J Med Genet 1989;34:237-245.
30. Singer N, Gersen S: The value of chromosome analysis in cases of neural tube defects: A case of anencephaly associated with fetal dup(2)(p24rpter). Prenat Diagn 1987;7:567-571.
31. Walbaum R, Peyrat MF, Van de Velde MF, Buerin DM, Bethouart M, Farriaux JP: Faut-il caryotyper les parents d'enfants atteints d'anomalies de fermeuture du tube neural? J Genet Hum 1984;32:307.
32. Winsor SHM, McGrath MJ, Khalifa M, Duncan AMV: A report of recurrent ancncephaly with trisomy 2p33-2pter: Additional evidence for the involvement of 2p24 in neural tube development and evaluation of the role for cytogenetic analysis. Prenat Diagn 1997;12:665-669.
33. Bogart MH, Cunniff C, Bradshaw C, Jones KL, Jones OW: Terminal deletions of the long arm of chromosome 7: Five new cases. Am J Med Genet 1990;36:53-55.
34. Machin GA, Crolla JA: Chromosome constitution of 500 infants dying during the perinatal period. Humangenetik 1974;23:183-198.
35. Brown S, Gersen S, Anyane-Yeboa K, Warburton D: Preliminary definition of a 'critical region' of chromosome 13 in q32: Report of 14 cases with 13q deletions and review of the literature. Am J Med Genet 1993;45:52-59.
36. Brandt CA, Hertz JM, Peterson MB, Vogel F, Noer H, Mikkelsen M: Ring chromosome 13: Lack of distinct syndromes based on different breakpoints on 13q. J Med Genet 1992;29:704-708.
37. Palmer CG, Miles JH, Howard-Pebbles PN, Magenis RE, Patil S, Friedman JM: Fetal karyotype following ascertainment of fetal anomalies by ultrasound. Prenal Diagn 1987;7:551-555.
38. Drugan A, Johnson MP, Dvorin E, et al: Aneuploidy with neural tube defects: Another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein. Fetal Ther 1989;4:88-82.
39. Schmid W, Mühlethaler JP, Briner J, Knechtli H: Ring chromosome 13 in a polymalformed anencephalic. Humangenetik 1975;27:63-66.
40. Shabtai F, Bichacho S, Halbrecht I: The fragile site on chromosome 16(q21q22): Data on four new families. Hum Genet 1980;55:19-22.
41. Macri JN, Buchanan PD, Gold MP: Low alpha-fetoprotein and trisomy. Lancet 1986;ii:405.
42. Nisani R, Chemke J, Cohen-Ankori H, Nissim F: Neural tube defects in trisomy 18. Prenat Diagn 1981;1:227-231.
43. Bird LM, Pretorius DH, Mendoza AE, Jones MC: Anencephaly with holoprosencephalic facies due to ring chromosome 18. Clin Dysmorphol 1997;6:351-358.
44. Seller MJ: Neural tube defects, chromosome abnormalities and multiple closure sites for the human neural tube. Clin Dysmorphol 1995;4:202-207.
45. Merrild U, Schiøler V, Christensen F, Wolny E, Edeling CJ: Anencephaly in trisome 18 associated with elevated alpha-1-fetoprotein in amniotic fluid. Hum Genet 1978;45:85-88.
46. Zumel RM, Darnaude MT, Delicado A, Diaz de Bustamante ML, de Torres I, Pajares L: Trisomy 20p from maternal translocation and anencephaly case report and genetic review. Ann Genet 1989;32:247-249.
47. Plaja A, Vendress T, Sarret E, Toran N, Mediano C: Terminal delection of Xp in a dysmorphic anencephalic fetus. Prenat Diagn 1994;14:401-412.
48. Malgorzata JM, Nowaczyk JA, Ramsay PM, Tomkins DJ: Multiple congenital anomalies in a fetus with 45, X/46, X.r(X)(p11/22q12) mosaicism. Am J Med Genet 1998;77:306-309.
49. Therkelsen AJ, Hulten M, Honasson J, Lindsten J, Christensen NC, Iversen T: Presumptive direct insertion within chromosome 2 in man. Ann Hum Genet 1973;36:367-373.
50. Fineman RM, Buyse M, Morgan M: Variable phenotype associated with duplication of different regions of 2p. Am J Med Genet 1983;15:451-456.
51. Nye JS, Balkin N, Lucas H, Knepper P, McLone D, Charrow J: Meningomyelocele and Waardenburg syndrome (type 3) in patients with interstitial deletion of 2q35 and the PAX 3 gene: Possible digenic inheritance of a neural tube defect. Am J Med Genet 1998;75:401-408.
52. McInyk AR, Muraskas J: Interstitial deletion of chromosome 2 region in a malformed infant. Am J Med Genet 1993;45:49-51.
53. Sarda P, Lefort G, Devaux PH, Humeau C, Rieu D: Multiple congenital anomalies due to partial 2p13r2pter duplication resulting from an unbalanced X;2 translocation. Ann Genet 1992;35:117-120.
54. Fear C, Briggs A: Familial partial trisomy of the long arm of chromosome 3 (3q). Arch Dis Childhood 1979;54:138.
55. Bader PI, Haney SM, Munsick RA, Schubert SR, Hodes ME: Brief clinical report: Neural tube defects in dup(11q). Am J Med Genet 1984;19:5-8.
56. McCorquodale M, Erickson RP, Robinson M, Roszczikpa K: Kleeblattschadel anomaly and partial trisomy for chromosome 13 (47,XY, +der(13), t(3,13)(q24; q14). Clin Genet 1980;17:409-414.
57. Seller MJ, Bergbaum A, Daker MG: Trisomy 9 in an embryo with spina bifida. Clin Dysmorphol 1998;7:217-219.
58. Benacerraf BR, Pauker S, Quade BJ, Bieber FR: Prenatal sonography in trisomy 9. Prenat Diagn 1992;12:175-181.
59. Golden JA, Schoene WC: Central nervous system malformations in trisomy 9. Neuropathol Exp Neurol 1993;52:71-77.
60. Frohlich G: Delineation of trisomy 9. J Med Genet 1982;19:316-317.
61. Park JP, McDermet MK, Doody AM, Marin-Padilla JM, Moeschler JB, Wurster-Hill DH: Familial t(11:13)(q21;q14) and the duplication 11q, 13q phenotype. Am J Med Genet 1993;45:46-48.
62. Najafzadeh T: Duplication of distal 11q and 22q occurrence in two unrelated families. Am J Med Genet 1981;8:341-347.
63. Rodriguez JI, Garcia M, Morales C, Morillo A, Delicado A: Trisomy 13 syndrome and neural tube defects. Am J Med Genet 1990;36:513-516.
64. Harmon JP, Hiet AK, Palmer CG, Golichowski AM: Triploidy: Pregnancy complications and clinical findings in seven cases. Ostet Gynecol 1995;86:595-597.
65. Nyberg DA, Shepard T, Mack LA, Hirsch J, Luthy D, Fitzsimmons J: Significance of a single umbilical artery in fetuses with central nervous system malformations. J Ultrasound Med 1988;7:265-273.
66. Holmes LB, Driscoll SG, Atkins L: Etiologic heterogeneity of neural-tube defects. N Engl J Med 1976;294:365-369.
67. Dunlap SS, Aziz MA, Rosenbaum KN: Comparative anatomical analysis of human trisoniies 13, 18 and 21. I. The Forelimb. Teratology 1986;33:159-186.
68. McFadden DE, Kalousek DK: Survey of neural tube defects in spontaneously aborted embryos. Am J Med Genet 1989;32:356-358.
69. Takeda K, Okamura T, Hasegawa T: Sibs with tetrasomy 18p born to a mother with trisomy 18p. J Med Genet 1989;26:195-197.
70. Claussen U, Ulmer R, Beinder E, Voigt HJ: Six years' experience with rapid karyotyping in prenatal diagnosis: Correlations between phenotype detected by ultrasound and fetal karyotype. Prenat Diagn 1994;14:113-121.
71. Williamson RA, Weiner CP, Murray J: Maternal serum alpha-fetoprotein in presence of both neural tube defects and chromosome anomalies. Lancet 1986;ii:757.
72. Fox JE, Gloster ES, Mirchandani R: Trisomy 18 with cantrell pentalogy in a stillborn infant. Am J Med Genet 1988;31:391-394.
73. Coerdt W, Miller K, Holzgreve W, Rauskolb R, Schwinger E, Rehder H: Neural tube defects in chromosomally normal and abnormal human embryos. Ultrasound Obstet Gynecol 1997;10:410-415.
74. Flannery DB, Kahler SG: Neural tube defects in trisomy 18. Prenat Diagn 1986;6:97-99.
75. Taylor AI: Autosomal trisomy syndromes: A detailed study of 27 cases of Edwards' syndrome and 27 cases of Patau's Syndrome. J Med Genet 1968;5:227-252.
76. Gullotta F, Rehder H, Gropp A: Descriptive neuropathology of chromosomal disorders in man. Hum Genet 1981;57:337-344.
77. Nickel RE, Magenis RE: Neural tube defects and deletions of 22q11. Am J Med Genet 1996;66:25-27.
78. Fryns JP, Devriendt K, Moerman PH: Lumbosacral spina bifida and myeloschizis in a female fetus with de novo x/autosomal translocation (t(X;22)(q27;q121)). Genet Couns 1996;7:159-160.
79. Graham JM, Fawnsley EF, Simmons GM, et al: Triploidy: Pregnancy complications and clinical findings in seven cases. Prenat Diagn 1989;9:409-419.
80. Creasy MR, Alberman ED: Congenital malformations of the central nervous system in spontaneous abortions. J Med Genet 1976;13:9-16.
81. Seller MJ, Greasey MR, Alberman ED: Alpha-fetoprotein levels in amniotic fluids from spontaneous abortions. Br Med J 1974;2:524-525.
82. Pitt D, Leversha M, Sinfield C, et al: Tetraploidy in a liveborn infant with spina bifida and other anomalies. J Med Genet 1981;18:309-311.
83. Davies JL, Kawaguchi Y, Bennett ST, et al: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994;371:130-136.
84. Saweer S, Jones HB, Feakes R, et al: A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13:464-476.
85. Harris MJ, Juriloff DM: Genetic landmarks for defects in mouse neural tube closure. Teratology 1997;56:177-187.
86. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T: A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 1995;10:175-180.
87. Hoth CF, Milunsky NL, Sheffer R, Clarren SK, Baldwin CT: Mutations in the paired domain of the human PAX3 gene cause Klien-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Gen 1993;52:455-463.
88. Baldwin CT, Hoth CF, Amos JA, daSilva EO, Milunski A: An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature 1992;355:637-638.
89. Hol FA, Hamel BCJ, Geurds MPA, et al: A frameshift mutation in the gene for PAX3 in a girl with spina bifida and mild signs of Waardenburg syndrome. J Med Genet 1995;32:52-56.
90. Moase CE, Trasler DG: Splotch locus mouse mutants: Models tor neural tube defects and Waardenburg syndrome type I in humans. J Med Genet 1992;29:145-151.
91. Chatkupt S, Hol FA, Shugart YY, et al: Absence of linkage between familial neural tube defects and PAX3 gene. J Med Genet 1995;32:200-204.
92. Spielman RS, Ewens WJ: The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Gen 1996;59:983-989.
93. Kirke PN, Mills JL, Whitehead AS, Molloy AM, Scott JM: Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 1996;348:1037-1038.
94. van der Put NM, Steegers-Theunissen RPM, Frosst P, et al: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1071.
95. Whitehead AS, Gallagher P, Mills JL, et al: A genetic defect in 5.10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995;88:763-766.
96. Speer MC, Worley G, Mackey JF, et al: The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. Neurogenetics 1997;1:149-150.
97. Hol FA, van der Put NM, Geurds MP, et al: Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects. Clin Genet 1998;53:119-125.
98. Barber RC, Shaw GM, Lammer EJ, et al: Lack of association between mutations in folate receptor-a gene and spina bifida. Am J Med Genet 1998;76:310-317.